MFG
RCKT icon

Merit Financial Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Merit Financial Group’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.2K Sell
19,360
-2,956
-13% -$9.83K ﹤0.01% 2266
2026
Q1 		$79.9K Buy
+22,316
New +$88.7K ﹤0.01% 2032

Other funds holding RCKT

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
OCWP
Owl Creek Wealth Partners Denver, Colorado $342M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Merit Financial Group's RCKT Position: Q2 2026 in Review

Merit Financial Group reduced its Rocket Pharmaceuticals (RCKT) stake by 13% in Q2 2026, selling an estimated $9.83K and leaving 19,360 shares worth $66.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2266.

Merit Financial Group first reported a position in RCKT in Q1 2026 and has held it in 2 quarters since. The position peaked at $79.9K in Q1 2026. 14 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Merit Financial Group held 19,360 shares of Rocket Pharmaceuticals worth $66.2K as of Q2 2026.
  • Merit Financial Group sold 2,956 Rocket Pharmaceuticals shares in Q2 2026, an estimated $9.83K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #2266 holding.
  • Merit Financial Group first reported a position in Rocket Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Merit Financial Group's Rocket Pharmaceuticals position peaked at $79.9K in Q1 2026.
  • 14 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.